Compile Data Set for Download or QSAR
maximum 50k data
Found 438 with Last Name = 'sharma' and Initial = 'g'
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537072(CHEMBL440072)
Affinity DataKi:  0.00500nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537063(CHEMBL4590517)
Affinity DataKi:  0.0130nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537077(CHEMBL4550617)
Affinity DataKi:  0.0150nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537069(CHEMBL4584764)
Affinity DataKi:  0.0150nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537066(CHEMBL4541310)
Affinity DataKi:  0.0150nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537076(CHEMBL4564727)
Affinity DataKi:  0.0180nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537061(CHEMBL4527856)
Affinity DataKi:  0.0220nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537068(CHEMBL4592483)
Affinity DataKi:  0.0610nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537070(CHEMBL4581874)
Affinity DataKi:  0.0750nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537074(CHEMBL4556000)
Affinity DataKi:  0.100nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537062(CHEMBL4549303)
Affinity DataKi:  0.120nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537067(CHEMBL4532058)
Affinity DataKi:  0.120nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537064(CHEMBL4563111)
Affinity DataKi:  0.140nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537075(CHEMBL4548228)
Affinity DataKi:  0.140nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537071(CHEMBL4581646)
Affinity DataKi:  0.180nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537065(CHEMBL4537192)
Affinity DataKi:  0.190nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537078(CHEMBL4577466)
Affinity DataKi:  0.260nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537073(CHEMBL4534477)
Affinity DataKi:  0.770nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537060(CHEMBL4575530)
Affinity DataKi:  0.970nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50432188(CHEMBL2346976)
Affinity DataKi:  2.20E+3nMAssay Description:Displacement of [3H]R1881 from full length androgen receptor in human LNCAP cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Tarveda Therapeutics

Curated by ChEMBL
LigandPNGBDBM50537079(CHEMBL4587303)
Affinity DataKi:  3.35E+3nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Rattus norvegicus (Rat))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50432188(CHEMBL2346976)
Affinity DataKi:  5.00E+3nMAssay Description:Binding affinity to rat androgen receptor ligand binding domain by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371616((R)-4-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl...)
Affinity DataIC50:  0.110nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Orchid Pharma

Curated by ChEMBL
LigandPNGBDBM14774(3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl...)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of human PDE4B using [3H]cAMP as substrate incubated for 5 mins followed by substrate addition and measured after 10 mins by scintillation...More data for this Ligand-Target Pair
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM50545552(CHEMBL4646742)
Affinity DataIC50:  0.400nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM50545560(CHEMBL4634421)
Affinity DataIC50:  0.400nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM50545558(CHEMBL4642748)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50347433(CHEMBL1801864)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of human Nampt after 3 hrs by counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM50545563(CHEMBL4636838)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50444655(CHEMBL3098518)
Affinity DataIC50:  0.600nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371523((R)-N-(6-Fluoropyridin-2-yl)-4-(2-(1-methyl-1H-pyr...)
Affinity DataIC50:  0.600nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM50545567(CHEMBL4649638)
Affinity DataIC50:  0.800nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50438931(CHEMBL2420634)
Affinity DataIC50:  1nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50438932(CHEMBL2420633)
Affinity DataIC50:  1nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371635((R)-4-(2-(1H-1,2,3-Triazol-1-yl)-4-(trifluoromethy...)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371776((R)-4-(2-(6-methylpyridin-3-yl)-4-(trifluoromethyl...)
Affinity DataIC50:  1.40nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM50545554(CHEMBL4635247)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371648((R)-N-(6-Fluoropyridin-2-yl)-4-(2-(2-methyloxazol-...)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50444654(CHEMBL3098517)
Affinity DataIC50:  1.70nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371652((R)-4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)...)
Affinity DataIC50:  1.80nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50444653(CHEMBL3098610)
Affinity DataIC50:  1.90nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50438961(CHEMBL2420638)
Affinity DataIC50:  2nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50435350(CHEMBL17289)
Affinity DataIC50:  2nMAssay Description:Inhibition of Nampt (unknown origin) using NAM/PRPP as substrate preincubated for 15 mins measured after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50444652(CHEMBL3098516)
Affinity DataIC50:  2nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50438933(CHEMBL2420632)
Affinity DataIC50:  2nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50435350(CHEMBL17289)
Affinity DataIC50:  2nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371770((R)-4-(2-(5-fluoropyridin-2-yl)-4-(trifluoromethyl...)
Affinity DataIC50:  2.10nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50444651(CHEMBL3098512)
Affinity DataIC50:  2.20nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM371697(N-(6-fluoropyridin-2-yl)-4-(2-morpholino-4-(triflu...)
Affinity DataIC50:  2.30nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Lupin

Curated by ChEMBL
LigandPNGBDBM50545556(CHEMBL4639228)
Affinity DataIC50:  2.30nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 438 total ) | Next | Last >>
Jump to: